7 Related NICE guidance
-
Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours.NICE technology appraisal guidance 86 (2004).
-
Sunitinib for the treatment of gastrointestinal stromal tumours. NICE technology appraisal guidance 179 (2009).